Oxadiazol-2-Oxide als Antischistosomale Mittel
EP2310378
Art A2
20. April 2011
Anmelder: The U.S.A. as represented by the Secretary, Department of Health and Human Services, Illinois State University, The U.S.A. As Represented By The Secretary, Department Of Health And Human Services 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP2310378
- Aktenzeichen
- EP09791490
- Anmeldetag
- 13. August 2009
- Veröffentlichung
- 20. April 2011
- Rechtsraum
- EP
- IPC
- C07D271/08C07D413/04A61K31/4245A61P33/12
Abstract
Für dieses Patent liegt uns kein Abstract vor.
Anmelder
- Firmen
- The U.S.A. as represented by the Secretary, Department of Health and Human Services
Illinois State University
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services - Land
- 🇺🇸 USA
🇺🇸
The U.S.A. as represented by the Secretary, Department of Health and Human Services
US-Bundesbehörde, unter deren Namen Forschungseinrichtungen wie die National Institutes of Health zahlreiche medizinische Patente anmelden. Kein Unternehmen im engeren Sinn, sondern eine Regierungsstelle.
605 Patente in unserer Datenbank